Flag of the European Union EU Clinical Trials Register Help

Clinical trials for 1

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44346   clinical trials with a EudraCT protocol, of which   7374   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    39,274 result(s) found for: 1. Displaying page 1,041 of 1,964.
    EudraCT Number: 2006-003133-33 Sponsor Protocol Number: EMG-2006 Start Date*: 2006-07-14
    Sponsor Name:Hôpital Erasme
    Full Title: Etude des effets d’un antagoniste non spécifique de l’endothéline (le bosentan) sur l’activité orthosympathique et le chémoréflexe.
    Medical condition: healthy subjects obstructive sleep apnea (Bosentan is used in clinic in pulmonary hypertension)
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2008-005105-18 Sponsor Protocol Number: ADX10059-205 Start Date*: 2008-11-04
    Sponsor Name:Addex Pharma SA
    Full Title: A phase 2B, randomised, double-blind, placebo-controlled, parallel group, dose-ranging, multi-centre study to investigate the efficacy, safety and tolerability of the mGluR5 negative allosteric mod...
    Medical condition: Gastroesophagal Reflux Disease
    Disease: Version SOC Term Classification Code Term Level
    9.1 10018203 GERD LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) SE (Completed) NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2004-003774-29 Sponsor Protocol Number: Acute GvHD Start Date*: 2005-12-21
    Sponsor Name:Therakos, Inc.
    Full Title: A Randomized, Controlled, Parallel-Group, Multicenter Study of Extracorporeal Photoimmune Therapy with Therakos "Uvadex" for the Treatment of Patients with Newly Diagnosed Acute Graft-Versus Host D...
    Medical condition: Graft-versus-Host Disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed) AT (Completed) BE (Completed) IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2011-004666-15 Sponsor Protocol Number: TMC-MDC-11-01 Start Date*: 2012-04-03
    Sponsor Name:The Medicines Company
    Full Title: A Phase II, double-blind, parallel group, dose-selection study to compare antifibrinolytic MDCO-2010 vs. placebo and tranexamic acid in reducing blood loss in patients undergoing primary cardiac su...
    Medical condition: Primary cardiac surgery involving cardiopulmonary bypass
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2019-002281-12 Sponsor Protocol Number: SJX-653-006 Start Date*: 2019-12-03
    Sponsor Name:Sojournix, Inc.
    Full Title: A phase 2, prospective, randomized, double-blind, placebo-controlled clinical study to assess the efficacy, safety, tolerability, and pharmacokinetics of SJX-653 in postmenopausal women with modera...
    Medical condition: Treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004872 10027311 Menopause flushing LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA) PL (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended) BE (Completed)
    Trial results: View results
    EudraCT Number: 2014-004032-19 Sponsor Protocol Number: NLOCEAN.505.14 Start Date*: 2015-09-09
    Sponsor Name:Radboud University Medical Center
    Full Title: A randomised, open-label clinical trial assessing the efficacy of octreotide to decrease iron infusion and blood transfusion requirements in patients with refractory anaemia due to gastrointestinal...
    Medical condition: small bowel angiodysplasias
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-003765-40 Sponsor Protocol Number: Start Date*: 2007-07-09
    Sponsor Name:Organisation name was not entered [...]
    1. Organisation name was not entered
    2. Respiratory research UNit
    Full Title: Bronkial respons på inhaleret Mannitol
    Medical condition: A population study of the response to Aridol, used as an asthma diagnostic
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2005-004824-38 Sponsor Protocol Number: MVDV 10/05 Start Date*: 2005-12-13
    Sponsor Name:UZ Leuven
    Full Title: Een gecombineerde spinale epidurale anesthesie (CSE) bij arbeid : nood aan een fluid load ?
    Medical condition: Combined spinal epidural analgesia during labour :necessity of a fluid load ?
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2020-002871-36 Sponsor Protocol Number: VIR-7831-5001 Start Date*: 2020-11-27
    Sponsor Name:Vir Biotechnology, Inc.
    Full Title: A randomized, multi-center, double-blind, placebo-controlled study to assess the safety and efficacy of monoclonal antibody VIR-7831 for the early treatment of coronavirus disease 2019 (COVID-19) i...
    Medical condition: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, the cause of coronavirus disease 2019 (COVID-19)
    Disease: Version SOC Term Classification Code Term Level
    23.1 10021881 - Infections and infestations 10084401 COVID-19 respiratory infection LLT
    23.0 10021881 - Infections and infestations 10084268 COVID-19 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2021-002474-99 Sponsor Protocol Number: GEM-2101 Start Date*: 2022-09-07
    Sponsor Name:Grupo Español Multidisciplinar de Melanoma (GEM)
    Full Title: Phase II, Open-Label Study of preliminary efficacy of Sitravatinib in Combination with Tislelizumab in Patients with Metastatic Uveal Melanoma with liver metastases.
    Medical condition: Metastatic Uveal Melanoma with liver metastases
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10081431 Uveal melanoma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-022871-78 Sponsor Protocol Number: 201009H1N1MHH Start Date*: 2010-11-10
    Sponsor Name:Medizinische Hochschule Hannover
    Full Title: A Phase II Study to Evaluate the Immunogenicity, Safety and Tolerability of a Seasonal Influenza Vaccine including H1N1 in Immunocompromised Adults Who Have Undergone Solid Organ Transplantation or...
    Medical condition: Vaccination for seasonal influenza including H1N1 of immunocompromised adults who have undergone solid organ or bone marrow transplantation and of healthy adults
    Disease: Version SOC Term Classification Code Term Level
    12.1 10022000 Influenza LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-003127-36 Sponsor Protocol Number: 47175798 Start Date*: 2006-03-14
    Sponsor Name:Matti Välimäki
    Full Title: Iäkkäään ihmisen D-vitamiinihoito: kaksi kertaa päivässä vai kolme kertaa vuodessa
    Medical condition: Iäkkään ihmisen D-vitamiinihoito
    Disease:
    Population Age: Gender: Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002932-27 Sponsor Protocol Number: 995 Start Date*: 2007-08-29
    Sponsor Name:Turun yliopistollinen keskussairaala
    Full Title: Population pharmacokinetics of dexmedetomidine in ICU patients
    Medical condition: Tutkimukseen otetaan 25 - 30 tehohoidossa olevaa potilasta, joille hoitavan lääkärin päätöksellä aloitetaan dexmedetomidiinisedaatio.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10022519 Intensive care LLT
    Population Age: Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-001501-42 Sponsor Protocol Number: 220668 Start Date*: 2008-05-15
    Sponsor Name:Jukka Sairanen
    Full Title: Tacrolimus in the treatment of Painful Bladder Syndrome / Interstitial Cystitis
    Medical condition: Painful bladder syndrome / interstitial cystitis (PBS/IC)
    Disease: Version SOC Term Classification Code Term Level
    1 10005063 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-001225-34 Sponsor Protocol Number: 290975 Start Date*: 2008-12-10
    Sponsor Name:Helsinki University Central Hospital
    Full Title: The influence of prime solution on the fluid balance after cardiac surgery.
    Medical condition: Sepelvaltimotauti I20.0 Aortaläppästenoosi I35.0
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-016842-22 Sponsor Protocol Number: MK01 Start Date*: Information not available in EudraCT
    Sponsor Name:photonamic GmbH & Co. KG
    Full Title: Evaluation of the suitability of PD L 506 for intraoperative visualisation of palpable and nonpalpable breast cancer tissue
    Medical condition: Breast cancer; palpable and non-palpable tumours of the female breast.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10006187 Breast cancer PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-022446-24 Sponsor Protocol Number: 2011-01 Start Date*: 2013-10-10
    Sponsor Name:Hospital of the Ludwig Maximilians University Munich
    Full Title: Active immunotherapy of patients with acute myeloid leukemia using autologous dendritic cells transfected with RNA encoding leukemia-associated antigens
    Medical condition: Male and female patients with AML of non-favorable risk profile not eligible for allogeneic stem cell transplantation
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004864 10000878 Acute myeloblastic leukemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-003786-14 Sponsor Protocol Number: AGO/2011/006 Start Date*: 2011-12-20
    Sponsor Name:Ghent University Hospital
    Full Title: Heeft het toedienen van ketamine of sevoflurane bij kinderen van 0 tot 14 jaar een meerwaarde tijdens het verwijderen van chirurgische thoraxdrains?
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10067564 Anaesthesia procedure PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2007-002860-86 Sponsor Protocol Number: 2007/099 Start Date*: 2007-06-26
    Sponsor Name:Radboud University Nijmegen Medical Centre
    Full Title: The adenosine receptor; a new pharmacological tool in the treatment of sepsis.
    Medical condition: Systemic inflammatory response
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2009-013118-28 Sponsor Protocol Number: Bucc-100-2009 Start Date*: 2009-08-28
    Sponsor Name:Tarja Heiskanen
    Full Title: Bukkaalinen fentanyyli syöpäpotilaiden toimenpidekivun hoidossa
    Medical condition: Cancer with metatases to the bone
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Jul 03 03:07:34 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA